Related Experiment Videos
Steroid receptors in benign mastectomy tissue
G J Netto1, J H Cheek, N Y Zachariah
1Department of Surgery, Baylor University Medical Center, Dallas, Texas 75246.
American Journal of Clinical Pathology
|July 1, 1990
Summary
Estrogen and progesterone receptor (ER and PR) levels were analyzed in breast tissue. Noncancerous mastectomy tissue showed higher ER and PR levels compared to benign breast tissue, with most ER-positive noncancerous tissue linked to ER-positive tumors.
Area of Science:
- Oncology
- Endocrinology
- Pathology
Background:
- Estrogen receptors (ERs) and progesterone receptors (PRs) are crucial biomarkers in breast cancer.
- Understanding receptor status in both cancerous and noncancerous breast tissue is important for treatment and prognosis.
Purpose of the Study:
- To compare ER and PR levels in cancerous, noncancerous mastectomy, and benign mammoplasty breast tissues.
- To investigate the association between receptor status in tumors and their corresponding noncancerous tissue.
Main Methods:
- Measurement of ER and PR levels using the Scatchard method.
- Analysis of 104 modified radical mastectomy specimens (cancerous and noncancerous components).
- Analysis of 14 benign breast specimens from reduction mammoplasty.
Main Results:
- Fourteen of 104 noncancerous mastectomy specimens were ER-positive (ER+).
- Most ER+ noncancerous tissues (13/14) were associated with ER+ tumors, but not vice versa (13/64 ER+ tumors had ER+ noncancerous counterparts).
- Average ER and PR levels were significantly higher in noncancerous mastectomy tissue than in mammoplasty specimens, despite similar histology.
Conclusions:
- Noncancerous breast tissue adjacent to tumors may exhibit altered receptor levels.
- The presence of ER/PR in noncancerous tissue may correlate with tumor receptor status, though the relationship is not absolute.
- Benign breast tissue from mastectomy specimens shows distinct receptor profiles compared to tissue from elective reduction mammoplasty.